Constance Nicastro-Bowman
Adult Health · Columbus, OHNPI 1942448816
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $23,643 of the $28,065 with a category attached, or 84.2%. 5 manufacturers reported payments, led by Bayer at 36.0% of the total. Reporting peaked in 2022 at $17,128 and has fallen 100.0% since, to $2 in 2025. Among adult health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $359.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$10K
- Vifor Pharma, Inc.$7K
- Fresenius USA Marketing, Inc.$6K
- Akebia Therapeutics Inc$5K
- Travere Therapeutics, Inc.$2
What the payments were for
- Consulting fees$1,0404%
- Speaking & faculty fees$23,64384%
- Travel & lodging$1,9767%
- Food & beverage$1,4055%
- Education$20%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 27 | $10,117 |
| Vifor Pharma, Inc. | 16 | $7,297 |
| Fresenius USA Marketing, Inc. | 21 | $5,921 |
| Akebia Therapeutics Inc | 12 | $4,727 |
| Travere Therapeutics, Inc. | 2 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$28,065 in reported general payments places this provider in the 95th percentile of 1,184 adult health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XphozahTenapanor Hcl | 14 | $49,572 |
| Sevelamer Carbonate | 18 | $3,708 |
| Nifedipine ErNifedipine | 27 | $1,106 |
| Valsartan | 37 | $1,051 |
| Calcium Acetate | 17 | $777 |
| Bumetanide | 14 | $710 |
| Carvedilol | 35 | $310 |
| Furosemide | 75 | $273 |
| Metoprolol Succinate | 23 | $245 |
| Doxazosin Mesylate | 24 | $156 |
| Gabapentin | 16 | $155 |
| Calcitriol | 16 | $155 |
| Olmesartan Medoxomil | 14 | $96 |
| Amlodipine Besylate | 25 | $84 |
| Lisinopril | 23 | $33 |
Paid to pharmacies, not to this prescriber.
Other adult health in Columbus
- Lucretia LongColumbus$76K
- Marybeth RivardColumbus$41K
- Michelle MormileColumbus$22K
- Kathleen MooreColumbus$17K
- Laura PopelarColumbus$17K
- James BetzColumbus$15K
- Mollie MoranColumbus$11K
- Jennifer ObrienColumbus$9K
- Karin AndersonColumbus$8K
- Megan JosephColumbus$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.